Key contraindications may include hypersensitivity to peptides, active malignancy and unmonitored self-medication
Calafatti M, Cocozza G, Limatola C, Garofalo S
PeptIQ helps you track every injection, log how you feel, and flag patterns across cycles so you actually know what's working
We've worked with hundreds of research teams navigating peptide reconstitution protocols
Wegovy is approved specifically for chronic weight management at doses up to 2.4 mg weekly in adults with a BMI of 30 kg/m (or 27 with a weight-related comorbidity)
Tesamorelin targets visceral belly fat and is FDA-approved for HIV-related lipodystrophy at about $1,500-$2,500 monthly